Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-07

Clinical Trial Update: Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating testosterone undecanoate for performance optimization during military operations; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Caloric Restriction, Exercise | Phase 4 | Status: COMPLETED | Results posted: 2022-10-07